Heini, Alexander D; Bacher, Ulrike; Pabst, Thomas (2024). Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL). British journal of haematology, 204(2), pp. 389-390. Wiley-Blackwell 10.1111/bjh.19195
Text
Br_J_Haematol_-_2023_-_Heini_-_Identification_of_novel_targets_for_immunotherapies_in_subsets_of_patients_with_diffuse.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (155kB) |
Personalized treatment options for subsets of patients with DLBCL are beginning to emerge. Caracciolo et al. explore UMG1, an epitope of CD43 as a potential target for certain patients with DLBCL, and demonstrate promising preclinical activity of an Anti-UMG1-antibody. Commentary on: Caracciolo et al. UMG1/CD3ε-bispecific T-cell engager (BTCE) redirects T-cell cytotoxicity against diffuse large B-cell lymphoma (DLBCL). Br J Haematol 2023 (Online ahead of print). doi: 10.1111/bjh.19183.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory |
UniBE Contributor: |
Heini, Alexander, Bacher, Vera Ulrike, Pabst, Thomas Niklaus |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0007-1048 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
16 Nov 2023 14:11 |
Last Modified: |
08 Feb 2024 00:13 |
Publisher DOI: |
10.1111/bjh.19195 |
PubMed ID: |
37964473 |
Uncontrolled Keywords: |
DLBCL UMG1 bispecific T-cell engager personalized medicine |
BORIS DOI: |
10.48350/188945 |
URI: |
https://boris.unibe.ch/id/eprint/188945 |